{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:08:01Z","timestamp":1774627681337,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.mcpro.2026.101522","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:28:18Z","timestamp":1769819298000},"page":"101522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2978-2267","authenticated-orcid":false,"given":"Miriam B.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3651-6802","authenticated-orcid":false,"given":"Bofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irtiza","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5596-5966","authenticated-orcid":false,"given":"Georgina","family":"El Hajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-9670","authenticated-orcid":false,"given":"David","family":"McCall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L.","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghayas C.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branko","family":"Cuglievan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein A.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2026.101522_bib1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41375-021-01309-y","article-title":"Therapeutic implications of menin inhibition in acute leukemias","volume":"35","author":"Issa","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.mcpro.2026.101522_bib2","series-title":"REVUFORJ(Revumenib) prescribing information","year":"2024"},{"key":"10.1016\/j.mcpro.2026.101522_bib3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2026.101522_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.24.00826","article-title":"Menin inhibition with revumenib for KMT2A-Rearranged relapsed or refractory acute leukemia (AUGMENT-101)","volume":"43","author":"Issa","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mcpro.2026.101522_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41375-024-02136-7","article-title":"Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche","volume":"38","author":"Chen","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.mcpro.2026.101522_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2026.101522_bib7","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1038\/s41467-023-42834-x","article-title":"NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing","volume":"14","author":"Feng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2026.101522_bib8","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1182\/blood.2024027244","article-title":"Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes","volume":"145","author":"Reville","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.mcpro.2026.101522_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2008-07-168617","article-title":"Differentiation syndrome in patients with acute promyelocytic leukemia treated with all- trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors","volume":"113","author":"Montesinos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.mcpro.2026.101522_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13045-021-01060-y","article-title":"Targeting chemokines for acute lymphoblastic leukemia therapy","volume":"14","author":"Hong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mcpro.2026.101522_bib11","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1002\/cam4.934","article-title":"CXCL9: evidence and contradictions for its role in tumor progression","volume":"5","author":"Ding","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.mcpro.2026.101522_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lfs.2019.04.053","article-title":"CXCL13\/CXCR5 signaling axis in cancer","volume":"227","author":"Hussain","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.mcpro.2026.101522_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595053","article-title":"Interleukin-33 promotes cell survival via p38 MAPK-mediated Interleukin-6 gene expression and release in pediatric AML","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2026.101522_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/leu.2017.261","article-title":"Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner","volume":"32","author":"Pe\u00f1a-Mart\u00ednez","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.mcpro.2026.101522_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3324\/haematol.2020.270421","article-title":"Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation","volume":"107","author":"Pe\u00f1a-Mart\u00ednez","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.mcpro.2026.101522_bib16","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gary Gilliland","year":"2002","journal-title":"Blood"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947626000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947626000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:12:37Z","timestamp":1774624357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947626000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1535947626000174"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2026.101522","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2026.101522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101522"}}